Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 82
Central Nervous System Drugs 67
Endocrine and Metabolic Disorders Drugs 50
Infusions and Injectables 33
Musculoskeletal Disorders Drugs 27
Surgical Procedures 21
Drug Discovery 20
Pharmaceuticals 20
Biopharmaceuticals 15
Prostate Cancer Drugs 13
Drug Delivery 13
Liver Cancer Drugs 10
Women's Health 10
Clinical Trials 10
Dermatology 10
Oncology 10
Neurology 9
Pancreatic Cancer Drugs 9
Medical Devices 8
Thyroid Cancer Drugs 8
Biotechnology 7
Lung Cancer Drugs 7
Healthcare Services 6
Breast Cancer Drugs 6
Genomics 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Company Reports 5
Immune Disorders Drugs 5
Kidney Cancer Drugs 5
Dermatological Drugs 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Enzymes 4
Sexual and Reproductive Health Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Ovarian Cancer Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Over the Counter (OTC) Drugs 3
Urological Disorders Drugs 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Needles and Syringes 2
Hematology 2
Surgical Devices 2
Hematological Drugs 2
Biosimilars and Biosuperiors 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Endocrinology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

452 Results (Page 16 of 23)
- Relevance
  Sort by

Liposome Drug Delivery - Global Strategic Business Report

 Report
October 2025
576 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Diffuse Large B-cell Lymphoma Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3997EUR$4,490USD£3,493GBP

Follicular Lymphoma Treatment Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3997EUR$4,490USD£3,493GBP

Primary Biliary Cholangitis Therapeutics - Global Strategic Business Report

 Report
October 2025
273 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Targeted Liposomes Drug Delivery - Global Strategic Business Report

 Report
October 2025
181 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1068EUR$1,200USD£933GBP

€1335EUR$1,500USD£1,167GBP

Small Cell Lung Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
100 Pages
Global

From

€2136EUR$2,400USD£1,867GBP

€2671EUR$3,000USD£2,334GBP

NUT Midline Carcinoma Treatment - Global Strategic Business Report

 Report
October 2025
383 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

United Kingdom Prostate Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
81 Pages
United Kingdom

From

€3116EUR$3,500USD£2,722GBP

Pituitary Cancer - Global Strategic Business Report

 Report
October 2025
575 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Esophageal Squamous Cell Carcinoma - Global Strategic Business Report

 Report
October 2025
275 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Neuroendocrine Carcinoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
June 2023
110 Pages
Global

From

€3500EUR$4,212USD£3,165GBP

Botox Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
February 2023
81 Pages
Global

From

€3500EUR$4,212USD£3,165GBP

Bladder Diseases Drug Market - Global Forecast to 2030

 Report
August 2025
187 Pages
Global

From

€3156EUR$3,545USD£2,758GBP

€3507EUR$3,939USD£3,064GBP

Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
140 Pages
Global

From

€4272EUR$4,799USD£3,733GBP

Carcinoid Syndrome Management Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
96 Pages
Global

From

€3500EUR$4,212USD£3,165GBP

The Top 100 Distributors of Anesthesia & Critical Care Equipment, Devices & Disposables Worldwide

 Report
June 2018
215 Pages
Global

From

€995EUR$1,197USD£900GBP

Acute Dystonia - Global Strategic Business Report

 Report
October 2025
372 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

 Report
February 2022
421 Pages
Global

From

€4272EUR$4,799USD£3,733GBP

Company Snapshots: France Pharmaceutical

 Newsletter
October 2025
35 Pages
France

From

€267EUR$300USD£233GBP

452 Results (Page 16 of 23)
- 1
- 14
- 15
- 16
- 17
- 18

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.